Department of Chemistry, Vertex Pharmaceuticals (Europe) Ltd., 88 Milton Park, Abingdon, Oxfordshire OX14 4RY, UK.
J Med Chem. 2011 Apr 14;54(7):2341-50. doi: 10.1021/jm101499u. Epub 2011 Mar 10.
Interleukin-2 inducible T-cell kinase (Itk) plays a role in T-cell functions, and its inhibition potentially represents an attractive intervention point to treat autoimmune and allergic diseases. Herein we describe the discovery of a series of potent and selective novel inhibitors of Itk. These inhibitors were identified by structure-based design, starting from a fragment generated de novo, the 3-aminopyrid-2-one motif. Functionalization of the 3-amino group enabled rapid enhancement of the inhibitory activity against Itk, while introduction of a substituted heteroaromatic ring in position 5 of the pyridone fragment was key to achieving optimal selectivity over related kinases. A careful analysis of the hydration patterns in the kinase active site was necessary to fully explain the observed selectivity profile. The best molecule prepared in this optimization campaign, 7v, inhibits Itk with a K(i) of 7 nM and has a good selectivity profile across kinases.
白细胞介素 2 诱导 T 细胞激酶 (Itk) 在 T 细胞功能中发挥作用,其抑制作用可能是治疗自身免疫和过敏疾病的一个有吸引力的干预点。本文描述了一系列新型强效和选择性 Itk 抑制剂的发现。这些抑制剂是通过基于结构的设计从从头生成的片段,即 3-氨基吡啶-2-酮基序发现的。3-氨基的功能化能够快速增强对 Itk 的抑制活性,而在吡啶酮片段的 5 位引入取代的杂芳环是实现对相关激酶最佳选择性的关键。对激酶活性位点的水合模式进行仔细分析对于充分解释观察到的选择性特征是必要的。在这一优化过程中制备的最佳分子 7v,对 Itk 的抑制常数 (Ki) 为 7 nM,对激酶具有良好的选择性。